US · guidance
CMS Pub. 100-03, ch. 1, § 160.2
Treatment of Motor Function Disorders with Electric Nerve
Stimulation
(Rev. 1, 10-03-03)
CIM 35-20
Not Covered
While electric nerve stimulation has been employed to control chronic intractable pain for
some time, its use in the treatment of motor function disorders, such as multiple sclerosis,
is a recent innovation, and the medical effectiveness of such therapy has not been verified
by scientifically controlled studies. Therefore, where electric nerve stimulation is
employed to treat motor function disorders, no reimbursement may be made for the
stimulator or for the services related to its implantation since this treatment cannot be
considered reasonable and necessary. See §§30.1 and 160.7.
NOTE: For Medicare coverage of deep brain stimulation for essential tremor and
Parkinson’s disease, see §160.25.
History
(Rev. 1, 10-03-03)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-08-25
- Edition
- iom-2026-08-25
- Content hash
fbdeb4b1fcb934db73d0f173e4dd53187459b838f97ee9162834b79227d44c59
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.